Robert Yarchoan

from Wikipedia, the free encyclopedia
Robert Yarchoan (1997)

Robert Yarchoan (born July 21, 1950 in New York City ) is an American medic .

Yarchoan grew up in Oceanside and studied at Amherst College with a bachelor's degree in 1971 and medicine from the University of Pennsylvania with an MD degree in 1975. He completed his internship and residency in internal medicine at the University of Minnesota and then as Immunologist at the National Cancer Institute (NCI), where he ended up in Samuel Broder's laboratory . In 1991 he became department head in the medical section of the NCI and in 1996 head of the newly established department for HIV . In 2007 he became the first director of the Office of HIV and AIDS Malignancy (OHAM) at NCI.

He belonged to the group at the NCI with Samuel Broder and the virologist Hiroaki Mitsuya (* 1950) who found the first effective drug against AIDS ( azidothymidine , zidovudine, AZT). They developed a drug test for AIDS and first examined known antivirals , including the AZT made available by Burroughts Wellcome, which was first synthesized by Jerome Horwitz in 1964 and was also found to block DNA replication. After clinical studies (led by Yarchoan) the drug was approved in the USA as early as 1987. He also directed the clinical trials on didanosine .

He is a Fellow of the American Association for the Advancement of Science and has received a number of awards for his AIDS research at the NCI and the NIH. He is an honorary doctorate from Amherst College.

Web links

Individual evidence

  1. Yarchoan, Robert. In: Who's who in the east. Marquis Who's Who, Chicago 1983.
  2. Derek Lowe, Das Chemiebuch, Librero 2017, p. 466